Your browser is no longer supported. Please, upgrade your browser.
Settings
PIRS Pieris Pharmaceuticals, Inc. daily Stock Chart
PIRS [NASD]
Pieris Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.71 Insider Own0.20% Shs Outstand45.47M Perf Week-12.59%
Market Cap227.35M Forward P/E- EPS next Y-0.95 Insider Trans470.51% Shs Float44.21M Perf Month-3.29%
Income-30.80M PEG- EPS next Q-0.22 Inst Own51.00% Short Float3.66% Perf Quarter-14.24%
Sales6.70M P/S33.93 EPS this Y-33.70% Inst Trans0.76% Short Ratio3.89 Perf Half Y115.52%
Book/sh0.22 P/B22.73 EPS next Y-11.80% ROA-50.00% Target Price9.00 Perf Year208.79%
Cash/sh1.11 P/C4.52 EPS next 5Y- ROE-146.70% 52W Range1.30 - 6.58 Perf YTD255.82%
Dividend- P/FCF29.91 EPS past 5Y- ROI-91.00% 52W High-24.01% Beta-
Dividend %- Quick Ratio2.90 Sales past 5Y- Gross Margin- 52W Low284.62% ATR0.30
Employees49 Current Ratio2.90 Sales Q/Q72.70% Oper. Margin- RSI (14)35.08 Volatility6.71% 5.86%
OptionableYes Debt/Eq0.00 EPS Q/Q-61.40% Profit Margin- Rel Volume0.82 Prev Close5.10
ShortableYes LT Debt/Eq0.00 EarningsNov 08 AMC Payout- Avg Volume415.72K Price5.00
Recom1.50 SMA20-13.41% SMA50-7.45% SMA20027.68% Volume340,930 Change-1.96%
May-30-17Initiated Rodman & Renshaw Buy $9
Aug-05-16Resumed ROTH Capital Buy
Aug-12-15Initiated JMP Securities Mkt Outperform
Jul-27-15Initiated Oppenheimer Outperform $8
Jul-22-15Initiated ROTH Capital Buy $7
Oct-17-17 09:56AM  ETFs with exposure to Pieris Pharmaceuticals, Inc. : October 17, 2017 Capital Cube
Oct-13-17 08:57PM  Is It Time To Buy Pieris Pharmaceuticals Inc (PIRS)? Simply Wall St.
07:10PM  Cramer's lightning round: Why I'm behind the stock of Cen... CNBC Videos
Oct-12-17 08:00AM  Pieris Pharmaceuticals Appoints Ingmar Bruns, M.D., Ph.D., as Vice President of Clinical Development Marketwired -5.78%
Oct-06-17 11:00AM  ETFs with exposure to Pieris Pharmaceuticals, Inc. : October 6, 2017 Capital Cube
Oct-05-17 09:32AM  Pieris Pharmaceuticals, Inc. :PIRS-US: Earnings Analysis: Q2, 2017 By the Numbers : October 5, 2017 Capital Cube
Sep-28-17 06:31PM  Edited Transcript of PIRS earnings conference call or presentation 10-Aug-17 2:00pm GMT Thomson Reuters StreetEvents +8.49%
Sep-26-17 08:00AM  Pieris Pharmaceuticals to Present at the LEERINK Partners Roundtable Series on Thursday, September 28 at 9:30 AM ET Marketwired
Sep-15-17 07:43AM  Is Pieris Pharmaceuticals Inc (PIRS) Undervalued? Simply Wall St.
Aug-10-17 08:00AM  Pieris Pharmaceuticals Appoints Allan Reine, M.D., as Chief Financial Officer Marketwired -7.40%
12:11AM  Pieris Pharmaceuticals reports 2Q loss Associated Press
Aug-09-17 05:20PM  Pieris Pharmaceuticals Reports Financial Results for the Second Quarter Ended June 30, 2017 and Provides Corporate Update Marketwired
Aug-01-17 07:30AM  Pieris Pharmaceuticals to Host Second Quarter 2017 Investor Call and Corporate Update on August 10, 2017 Marketwired
Jul-12-17 10:35AM  OpCo On Biotech: 'Our Bullishness Is Unabated' Barrons.com
Jul-05-17 04:30PM  Pieris Pharmaceuticals Announces Results from 2017 Annual Meeting of Stockholders and Provides Update on Therapeutic Programs Marketwired +6.04%
Jul-04-17 03:21PM  ETFs with exposure to Pieris Pharmaceuticals, Inc. : July 4, 2017 Capital Cube
Jun-30-17 04:09PM  Penny Stocks to Watch for July 2017 Investopedia
Jun-28-17 03:30PM  These 3 Small Biotechs Have a Healthy Shot TheStreet.com
Jun-27-17 08:00AM  Pieris Pharmaceuticals Added to the Russell 2000(R) and Russell 3000(R) Indexes Marketwired
Jun-12-17 08:30AM  Pieris Pharmaceuticals Announces Expiration of HSR Waiting Period for Collaboration with AstraZeneca Marketwired
Jun-04-17 07:00AM  Pieris Pharmaceuticals Announces Presentation of Clinical Data for Anemia Drug Candidate, PRS-080, at the 54th ERA-EDTA Congress Marketwired
Jun-02-17 10:12AM  Pieris Pharmaceuticals, Inc. :PIRS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017 Capital Cube
Jun-01-17 06:19PM  Pieris Pharmaceuticals to Present at The Jefferies 2017 Global Healthcare Conference on Friday, June 9th at 9:00 am EDT Marketwired +5.24%
May-22-17 04:32PM  Pieris Pharmaceuticals Appoints James Geraghty to its Board of Directors Marketwired
May-10-17 07:20PM  Pieris Pharmaceuticals reports 1Q loss Associated Press +17.06%
05:36PM  Pieris Pharmaceuticals Reports Financial Results for the First Quarter Ended March 31, 2017 and Provides Corporate Update Marketwired
May-04-17 08:15AM  Blog Coverage: Pieris Announces Collaboration with AstraZeneca Accesswire
May-03-17 10:05AM  Boston-based Pieris adds AstraZeneca as R&D partner in $45M deal American City Business Journals +52.92%
08:14AM  Pieris Pharma stock soars 54% on news of $57.5 mln AstraZeneca deal MarketWatch
07:30AM  Pieris Pharmaceuticals to Host Conference Call on Strategic Alliance With AstraZeneca Marketwired
03:10AM  AstraZeneca boosts early respiratory medicine with Pieris deal Reuters
02:00AM  Pieris Pharmaceuticals and AstraZeneca Collaborate to Develop and Commercialize Anticalin-Based Inhaled Treatments for Respiratory Diseases Marketwired
May-01-17 07:30AM  Pieris Pharmaceuticals to Host First Quarter 2017 Investor Call and Corporate Update on May 11, 2017 Marketwired
Apr-04-17 07:30AM  Pieris Pharmaceuticals Presents IND-enabling Data for Bispecific Immuno-Oncology Drug Candidate, PRS-343, in Poster Session at the 2017 Meeting of the American Association for Cancer Research (AACR) Marketwired
07:30AM  Pieris Pharmaceuticals Presents IND-enabling Data for Bispecific Immuno-Oncology Drug Candidate, PRS-343, in Poster Session at the 2017 Meeting of the American Association for Cancer Research (AACR)
Mar-31-17 01:36PM  Pieris Pharmaceuticals, Inc. :PIRS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 31, 2017 Capital Cube
01:36PM  Pieris Pharmaceuticals, Inc. :PIRS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 31, 2017
10:40AM  Pieris Pharmaceuticals, Inc. :PIRS-US: Earnings Analysis: 2016 By the Numbers : March 31, 2017
Mar-30-17 06:04AM  PIERIS PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report
Mar-23-17 06:04AM  PIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
Mar-22-17 08:18PM  Pieris Pharmaceuticals Reports Full-Year 2016 Financial Results and Corporate Update Marketwired
08:36AM  PIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Mar-15-17 07:30AM  Pieris Pharmaceuticals to Host Full-Year 2016 Investor Call And Corporate Update on March 23, 2017 Marketwired
Mar-14-17 07:30AM  Pieris Pharmaceuticals to Present at Oppenheimer's 27th Annual Healthcare Conference, Wednesday, March 22nd at 11:30 am EDT Marketwired
Mar-07-17 07:30AM  Pieris Pharmaceuticals to Present at the 29th Annual Roth Conference Monday, March 13th at 2:00 pm PST Marketwired
Mar-06-17 07:30AM  Pieris Pharmaceuticals Announces Presentation of IND-enabling Data for Bispecific Immuno-Oncology Drug Candidate, PRS-343, at the 2017 Meeting of the American Association for Cancer Research (AACR) Marketwired +18.92%
Mar-01-17 08:00AM  Pieris Pharmaceuticals to Present at the Cowen and Company 37th Annual Health Care Conference on March 6th at 4:40 pm EST Marketwired
Feb-27-17 08:22AM  Pieris Pharmaceuticals' stock soars after exclusive license deal with Japan's ASKA MarketWatch +5.21%
08:22AM  Pieris Pharmaceuticals' stock soars after exclusive license deal with Japan's ASKA at MarketWatch
07:30AM  Pieris Signs 1st Partnership for Anemia Drug PRS-080, Granting Exclusive Option in Japan to ASKA Pharmaceutical Marketwired
Feb-08-17 07:30AM  Pieris Pharmaceuticals to Present at the Bio CEO Investor Conference on February 13th at 1:30 pm EST Marketwired
Feb-07-17 05:22PM  PIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Change in Directors
05:21PM  Pieris Announces Management Transition Marketwired
Jan-09-17 06:08AM  PIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jan-05-17 07:30AM  Pieris Pharmaceuticals to Host Investor Call Today to Discuss Servier Collaboration Marketwired +19.74%
07:06AM  PIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and
07:00AM  Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncology Co-development Alliance Marketwired
Dec-16-16 10:11PM  What Hedge Fund Sentiment Says About Pieris Pharmaceuticals Inc (PIRS) And Its Peers at Insider Monkey
Dec-01-16 08:00AM  Pieris Pharmaceuticals Appoints Claude Knopf as Chief Business Officer Marketwired
Nov-18-16 01:04PM  PIERIS PHARMACEUTICALS, INC. Financials
Nov-11-16 11:31AM  Pieris Pharmaceuticals, Inc. :PIRS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016
Nov-10-16 08:32AM  PIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
Nov-09-16 06:01PM  Pieris Pharmaceuticals reports 3Q loss +7.14%
05:50PM  Pieris Pharmaceuticals Reports Financial Results and Provides Corporate Update for the Third Quarter Ended September 30, 2016 Marketwired
Nov-01-16 08:00AM  Pieris Pharmaceuticals to Host Third Quarter 2016 Investor Call and Corporate Update on November 10, 2016 Marketwired
Oct-26-16 08:00AM  Pieris Pharmaceuticals to Receive GLP Tox Milestone Payment in Daiichi Sankyo Collaboration Marketwired
Oct-24-16 07:59AM  PIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Oct-20-16 08:00AM  Pieris Announces Presentations at Upcoming R&D Conferences Marketwired
Oct-05-16 05:27PM  PIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and
Sep-28-16 10:30AM  PIRS: Positive Preclinical Data Presented for PRS-343
Sep-26-16 05:15PM  Pieris Pharmaceuticals Presents Positive Data for Its Lead Bispecific Drug Candidate, PRS-343, at the 2016 CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference Marketwired
Sep-22-16 10:26AM  PIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and +5.03%
08:00AM  Pieris Pharmaceuticals Appoints Christopher Kiritsy to Its Board of Directors Marketwired
Sep-07-16 08:30AM  Pieris Pharmaceuticals Announces Presentation of Data for Its Lead IO Bispecific Program, PRS-343, at the 2016 CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference Marketwired
Sep-01-16 10:31AM  Pieris Pharmaceuticals to Present at Rodman & Renshaw 18th Annual Global Investor Conference Marketwired
Aug-12-16 04:00PM  PIRS: Development of Multiple Anticalin® Products Continues
11:22AM  Pieris Pharmaceuticals, Inc. :PIRS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
Aug-11-16 09:26AM  PIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
Aug-10-16 05:05PM  Pieris Pharmaceuticals reports 2Q loss
05:00PM  Pieris Pharmaceuticals Reports Financial Results and Provides Corporate Update for the Second Quarter Ended June 30, 2016 Marketwired
Aug-01-16 08:00AM  Pieris Pharmaceuticals to Host Second Quarter 2016 Investor Call and Corporate Update on August 11, 2016 Marketwired
Jul-26-16 09:23AM  PIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and
08:00AM  Pieris Pharmaceuticals Appoints Julian Adams, Ph.D., to Its Board of Directors Marketwired
Jul-14-16 11:58AM  5 Stocks Under $10 Set to Soar
Jul-01-16 08:49AM  PIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to
Jun-14-16 07:59AM  Pieris Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences Marketwired
Jun-09-16 05:23PM  PIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events -5.43%
Jun-08-16 05:02PM  PIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
11:20AM  Pieris Pharmaceuticals Announces Closing of $16.5 Million Private Placement Marketwired
Jun-06-16 08:01AM  PIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Jun-03-16 09:00AM  Pieris Pharmaceuticals Announces $16.5 Million Private Placement Marketwired
Jun-01-16 03:22PM  Pieris Pharmaceuticals, Inc. :PIRS-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016
May-19-16 11:39AM  5 Stocks Under $10 Set to Soar
May-18-16 03:30PM  PIRS: PRS-343 Shows Efficacy in Humanized Mouse Cancer Model
May-12-16 09:41AM  PIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements -5.60%
May-11-16 05:04PM  Pieris Pharmaceuticals reports 1Q loss
05:00PM  Pieris Pharmaceuticals Reports Financial Results and Corporate Update for the First Quarter Ended March 31, 2016 Marketwired
Apr-27-16 08:00AM  Pieris Pharmaceuticals to Host First Quarter 2016 Investor Call and Corporate Update on May 12, 2016 Marketwired -6.82%
Apr-18-16 07:06AM  PIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Apr-07-16 04:17PM  PIERIS PHARMACEUTICALS, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements
Pieris Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, discovers and develops Anticalin-based drugs. It develops Anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in blood plasma and other bodily fluids. The company primarily focuses on the development of four drug candidates, including PRS-080 designed to target hepcidin for the treatment of functional iron deficiency in anemic patients with chronic kidney disease or in end-stage renal disease patients requiring dialysis; PRS-060, a drug candidate that binds to the IL-4RA receptor alpha-chain, which is used for the treatment of asthma and other inflammatory diseases; PRS-343, a bispecific protein for oncology diseases; and PRS-332, a bispecific anticalin-antibody fusion protein for oncology diseases. It has strategic partnership agreements with Allergan, Inc.; Sanofi Group; Daiichi Sankyo Company Limited; F.Hoffmann- La Roche Ltd. and Hoffmann- La Roche Inc.; ASKA Pharmaceutical Co., Ltd; and Les Laboratoires Servier and Institut de Recherches Internationales. The company also has a research and licensing agreement with Technische Universitat Munchen; and a collaboration agreement with AstraZeneca. Pieris Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GERAGHTY JAMES ADirectorAug 17Buy4.8210,00048,20010,000Aug 17 07:20 PM
Reine AllanSee RemarksAug 17Buy4.8920,00097,80065,000Aug 17 07:19 PM
Reine AllanSee RemarksAug 16Buy4.7945,000215,55045,000Aug 17 07:19 PM
KIRITSY CHRISTOPHER PDirectorApr 21Option Exercise1.595,0007,9505,000May 09 06:30 PM